The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy
Fidler, I.J.; Poste, G.
Seminars in Oncology 12(3): 207-221
1985
ISSN/ISBN: 0093-7754 PMID: 4048964 Document Number: 257247
Document emailed within 1 workday
Related Documents
Krylov, N.L.; Polenko, V.K.; Zabelin, V.A.; Rutkovskiĭ, V.V. 1982: Chemotherapy of malignant neoplasms Voenno-Meditsinskii Zhurnal 5: 32-36Bukhny, A.F.; Zikiriakhodzhaev, D.Z. 1986: Chemotherapy of malignant neoplasms in children Meditsinskaia Sestra 45(3): 42-44
Ichihashi, H.; Yamauchi, M.; Watanabe, T.; Takagi, H.; Kondo, T. 1988: Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer (2d report)--6-year survival after surgery: Tokai Cooperative Study Group of Surgical Adjuvant Chemotherapy Gan no Rinsho. Japan Journal of Cancer Clinics 34(4): 451-456
Bollack, C.; Jacqmin, D.; Splinter, T.A.; De Pauw, M. 1988: Non-adjuvant chemotherapy of bladder neoplasms stage T3-4 using NO-x and MO. Preliminary results of the urogenital study group of the European Organization for Research and Treatment of Cancer Casopis Lekaru Ceskych 127(35): 1098-1100
Fedina, V.A.; Dement'eva, N.I. 1970: C-reactive protein in patients with malignant neoplasms during chemotherapy Klinicheskaia Meditsina 48(11): 128-132
Singer, Z. 1974: Chemotherapy of malignant neoplasms in Internal Medicine Departments Polski Tygodnik Lekarski 29(49): 2139-2142
Valle, G.; Carmignani, M.; Brunetti, L.; Volpe, A.R. 2011: Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas Journal of BUON: Official Journal of the Balkan Union of Oncology 16(4): 787; Author Reply 787-8
Urban, K. 1982: Adjuvant chemotherapy of malignant bone tumors at the Orthopedic Clinic in Hradci Králové Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 25(5): 535-543
Kawai, A. 2018: Musculoskeletal Tumor Adjuvant Chemotherapy for Malignant Bone and Soft Tissue Tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(3): 428-429
Hurlbut, H.J.; Sumner, W.C. 1976: Arterial infusion chemotherapy for palliation in far-advanced malignant neoplasms American Surgeon 42(2): 116-122
Yamada, N.; Abe, N.; Usui, K.; Noda, H.; Tanaka, Y.; Tanai, C.; Ejima, M.; Ishihara, T. 2010: Clinical analysis of 12 cases of pneumothorax during intensive chemotherapy for malignant neoplasms Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(8): 1519-1523
Liubaev, V.L.; Poliakov, B.I. 1971: Possibilities of systemic chemotherapy with methotrexate in the treatment of neglected forms of malignant neoplasms of the head and neck Vestnik Akademii Meditsinskikh Nauk SSSR 26(3): 70-73
Madej, G.; Zborzil, J.; Siedlecki, P. 1979: Results of chemotherapy with bleomycin and vinblastine of malignant testicular neoplasms at the Warsaw Institute of Oncology in the years 1977-1978 Polski Tygodnik Lekarski 34(47): 1821-1824
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
Sternberg, C.N.; Yagoda, A.; Scher, H.I.; Whitmore, W.F.; Herr, H.W.; Morse, M.J.; Sogani, P.C.; Bosl, G.; Watson, R.C.; Hollander, P.S. 1988: Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy Progress in Clinical and Biological Research 260: 551-555
Todoroki, T. 2000: Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery Hepato-Gastroenterology 47(33): 644-649
Płuzańska, A.; Dyczka, J.; Stempoczyńska, J.; Wator, A.; Alwasiak, J. 1997: Two primary malignant neoplasms and recurrent neoplasms in patients treated at the Regional Cancer Center in Lodź in 1976-1989 Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 2(10): 277-280
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Shi, L.; Zhou, S.; Jiang, Y.; Wan, Y.; Ma, J.; Fu, S.; Cheng, W. 2014: Gynecological malignant tumor related multiple primary malignant neoplasms: clinical analysis of 30 cases Zhonghua Fu Chan Ke Za Zhi 49(3): 199-203
Senn, H.J. 1982: Adjuvant therapy in breast neoplasms Aktuelle Probleme in Chirurgie und Orthopadie 22: 52-60